• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Veracyte

edit

Veracyte, Inc. develops diagnostics for thyroid and non-small cell lung cancer. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. The company was incorporated in 2006 and is based in South San Francisco, California.

Milestones

edit

• 
  Veracyte added Mark Spring as CFO.
  Posted 1/31/12 at 7:29pm
• 
  Veracyte added Chris Hall as Chief Commercial Officer.
  Posted 6/13/10 at 10:28pm
• 
  Veracyte added Bonnie Anderson as Cofounder and CEO.
  Posted 6/13/10 at 10:28pm
• 
  Veracyte received $28M in Series B funding. (6/11/10)
  Posted 6/13/10 at 10:28pm via onbiovc.com

Videos

Screenshots

edit

Sources

1. Veracyte, Inc.: Series B $28M (onbiovc.com) [edit]